FDA chief nominee Scott Gottlieb’s changes may pressure generic drug prices, but there are other positives for the sector.
WSJ.com: Health, Wall Street Journal: Business: Health
Tue, 03/14/2017 - 9:44am
FDA chief nominee Scott Gottlieb’s changes may pressure generic drug prices, but there are other positives for the sector.